NeuroOne Medical Technologies (NASDAQ:NMTC) Announces Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTC) issued its quarterly earnings data on Tuesday. The company reported ($0.11) earnings per share for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative return on equity of 276.12% and a negative net margin of 308.51%.

NeuroOne Medical Technologies Price Performance

Shares of NASDAQ NMTC opened at $0.74 on Thursday. The stock has a market capitalization of $22.80 million, a PE ratio of -1.54 and a beta of 0.54. NeuroOne Medical Technologies has a fifty-two week low of $0.55 and a fifty-two week high of $1.72. The business has a fifty day moving average price of $0.82 and a two-hundred day moving average price of $0.84.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.